DataMeds AI, Inc.
NNASDAQ:MEDSRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- DataMeds AI, Inc., formerly known as Trxade Health, Inc., is a health technology and data intelligence company that operates web-based pharmaceutical procurement marketplaces, digital healthcare platforms, and artificial intelligence-driven supply chain analytics solutions in the United States. The company operates through digital pharmaceutical commerce, telehealth, and healthcare data technology segments, catering to independent pharmacies, healthcare clinics, wholesale distributors, drug manufacturers, institutional providers, and retail consumers. DataMeds AI, Inc. offers a systematic suite of proprietary platforms and services, including TRxADE, a business-to-business (B2B) digital marketplace platform that allows licensed pharmacies and healthcare facilities to compare real-time pricing, purchase inventory, and procure brand-name, generic, and over-the-counter (OTC) pharmaceuticals; Bonum Health, a digital telemedicine platform providing on-demand virtual clinical consultations, remote care management, and employer healthcare solutions; DelivMeds, a mobile application facilitating patient medication management, prescription refills, and last-mile pharmacy delivery services; IntegraCheck, a supply chain security and compliance verification tool for pharmaceutical pedigree authentication; and AI-driven data intelligence software providing predictive procurement analytics, automated inventory forecasting, pricing trend modeling, and purchasing workflow optimization. In recent developments, the company completed a major corporate reorganization and name change to DataMeds AI, Inc. to align its corporate identity with its strategic transition toward artificial intelligence, predictive healthcare data analytics, and algorithmic supply chain infrastructure. Over the past two years, the company has divested non-core legacy assets, formed strategic technology alliances to integrate machine learning capabilities across its digital commerce ecosystem, expanded its predictive procurement software offerings for institutional buyers, and initiated operational restructuring programs to accelerate the deployment of AI-enabled pharmaceutical trade solutions. DataMeds AI, Inc. was founded in 2010 and is headquartered in Tampa, Florida.
Company News
DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License
DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
DataMeds Regains Compliance With NASDAQ Listing Standards
Contrasting Wellgistics Health (NASDAQ:MEDS) & Hims & Hers Health (NYSE:HIMS)
DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test
DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers
Datameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment
DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
Wellgistics Health, Inc. (NASDAQ:MEDS) Stock Short Interest Rises 147.5%
DataMeds AI Stock Surges on Mobile App Launch
DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
DataMEDS AI Unveils New Corporate Website
DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked
This AI stock experienced a 5x rally on Wednesday
DataMEDS AI Stock Surges Wednesday: What's Driving the Action?